YU34793A - Derivati proteina c - Google Patents

Derivati proteina c

Info

Publication number
YU34793A
YU34793A YU34793A YU34793A YU34793A YU 34793 A YU34793 A YU 34793A YU 34793 A YU34793 A YU 34793A YU 34793 A YU34793 A YU 34793A YU 34793 A YU34793 A YU 34793A
Authority
YU
Yugoslavia
Prior art keywords
flin
pgt
nrrl
coli
group
Prior art date
Application number
YU34793A
Other languages
English (en)
Inventor
E.B. Gerlitz
W.B. Grinnell
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Priority to YU34793A priority Critical patent/YU34793A/sh
Publication of YU34793A publication Critical patent/YU34793A/sh

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Derivat ljudskog proteina C odabran iz grupe koja se sastoji od Q3Q9, FLIN-Q313 i FLIN-Q3Q9; rekom-binantni molekul DNK odabran iz grupe koja se sastoji od plazmida pGT-h-Q3Q9 (NRRL B-18938), plazmida pGT-h-FLIN-Q313 (NRRL B-18939) i plazmida pGT-h-FLIN-Q3Q9 (NRRL B-18940); ćelija domaćin koja predstavlja 293/pGT-h-Q3Q9, 293/pGT-h-FLIN-Q3Q13, 293/pGT-h-FLIN-Q3Q9, E. coli K12 AG1/pGTQ3Q9 (NRRL B-18938), E. coli K12 AG1/pGT-h-FLIN-Q313 (NRRL B-18939) i E. coli K12 AG1/pGT-h-FLIN-Q3Q9 (NRRL B-18940); i farmaceutska formulacija koja obuhvata kao aktivnu komponentu derivat proteina C odabran iz grupe koja se sastoji do Q3Q9, FLIN-Q313 i FLIN-Q3Q9, zajedno sa jednim ili više farmaceutski prihvatljivih nosača, ekscipijenata ili razblaživača.
YU34793A 1993-05-19 1993-05-19 Derivati proteina c YU34793A (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU34793A YU34793A (sh) 1993-05-19 1993-05-19 Derivati proteina c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU34793A YU34793A (sh) 1993-05-19 1993-05-19 Derivati proteina c

Publications (1)

Publication Number Publication Date
YU34793A true YU34793A (sh) 1996-02-19

Family

ID=47553619

Family Applications (1)

Application Number Title Priority Date Filing Date
YU34793A YU34793A (sh) 1993-05-19 1993-05-19 Derivati proteina c

Country Status (1)

Country Link
YU (1) YU34793A (sh)

Similar Documents

Publication Publication Date Title
KR930023370A (ko) 단백질 씨(c) 유도체
HRP20020880B1 (en) New pharmaceutical composition
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
ATE285241T1 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
DK0609210T3 (da) Optisk aktivt 5H-pyrrolo(3,4-b)pyrazinderivat, dets fremstilling og farmaceutiske præparater deraf
NO911854D0 (no) Fremgangsmaate for fremstilling av peptid-derivater.
AU7207098A (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
BR9709845B1 (pt) preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina.
BG101118A (en) Therapeutical compounds
PH27257A (en) Therapeutically active chloro substituted benzimidazole
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
NO302170B1 (no) Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav
YU34793A (sh) Derivati proteina c
RS49520B (sr) Antimikrobno aktivne smeše
NO921563L (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
ES2126580T3 (es) Proteina condromodulina-ii.
FR2688504B1 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR2681320B1 (fr) Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
BR9106372A (pt) Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
ES2067842T3 (es) Uso del factor de necrosis tumoral.
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
DE69316621T2 (de) Antivitale zusammensetzungen
FI935915A (fi) 2-tienyyli-imidatso(2,1-b)bentsotiatsol-3-etikkahappojohdannaiset, niiden valmistus ja terapeuttinen käyttö